We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2057:HKEXZTO Express (Cayman) Inc. Analysis

Data as of 2026-08-24 - not real-time

HK$164.10

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

ZTO Express (Cayman) Inc. trades at HKD 164.10, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. Over a rolling month the price has lost 12.6%. RSI sits at 28.2, which reads as oversold, and MACD momentum is bearish. Recent trading has carved out support near HKD 163.60 and resistance around HKD 194.80.
The shares look undervalued, trading on 11.0 times earnings below a sector average of 29.7. The average analyst target implies 33.7% above today's level. Revenue is growing at 23.0% on a 19.0% profit margin. The 3.18% dividend yield looks covered by current payout levels.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 27.4%, a beta of 0.21 and a maximum drawdown of 19.6%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to buy, carrying 9/10 conviction.

Top Market Events

ZTO Express Cayman Inc. NYSE: ZTO and HKEX: 2057 , a leading and fast-growing express delivery company in China "ZTO"...SHANGHAI, July 23, 2026 /PRNewswire/ -- ZTO Express Cayman Inc.ZTO Express Cayman Inc. NYSE: ZTO and SEHK: 2057 , a leading and fast-growing express delivery company in China "ZTO"...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • RSI at 28.2 signals oversold conditions
  • Trading below the 200-day average of 178.11

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • RSI at 28.2 signals oversold conditions
  • P/E of 11.0 versus sector average of 29.7

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • P/E of 11.0 versus sector average of 29.7
  • Analyst targets imply +33.7% versus the current price
  • Profit margin of 19.0% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth23.00%
Profit Margin19.04%
P/E Ratio11.0
ROE16.28%
ROA7.38%
Debt/Equity34.58
P/B Ratio1.7
Op. Cash FlowHK$14.8B
Free Cash FlowHK$6.4B
Industry P/E29.7

Technical Analysis

TrendBullish
RSI28.2
SupportHK$163.60
ResistanceHK$194.80
MA 20HK$182.91
MA 50HK$182.06
MA 200HK$178.11
MACDBearish
VolumeIncreasing
Fear & Greed Index93.13

Valuation

Fair ValueHK$286.59
Target PriceHK$219.35
Upside/Downside33.67%
GradeUndervalued
TypeBlend
Dividend Yield3.18%

Risk Assessment

Beta0.21
Volatility27.43%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.